CuFe (ASX:CUF) received notice that European Lithium (ASX:EUR) decreased their holdings in the company to 16.7% from 17.9%, according to a Monday Australian bourse filing.
European Lithium now owns 342.4 million shares in the company, the filing said.
(Updates to add stock movement in the headline and last paragraph)Charter Hall Group (ASX:CHC) increased its fiscal 2026 guidance for operating earnings to AU$1.03 per security from AU$1 previously, according to a Monday filing with the Australian bourse.The new outlook represents a nearly 27% increase on fiscal 2025 operating earnings per security of AU$0.814.The company said its financial year-to-date gross equity inflows total AU$6.5 billion, up by AU$1.7 billion since the first half of fiscal 2026.Charter Hall Group also recorded the addition of 25 new institutional investors to its platform over the last 18 months, with property funds under management increasing to AU$74.7 billion from AU$71.7 billion at the end of 2025.The company continues to expect fiscal 2026 distribution per security to be 6% higher than fiscal 2025.The company's shares rose around 6% in recent Monday trade.
AMP's (ASX:AMP) superannuation arm, AMP Super, introduced a new retirement package designed to convert superannuation savings into a lifetime income stream, aiming to improve retirement confidence and provide additional support for aged-care needs, according to a Monday statement.The package offers a guaranteed lifetime income product to support higher retirement spending, a temporary 20% income boost for up to two years for those needing high-level home care, and a digital financial advice platform that provides personalized guidance, income projections, and retirement planning tools.The initiative addresses Australians' rising concerns about retirement stress and aged-care affordability by strengthening income stability and later-life care support, per the statement.
Divi's Laboratories' (NSE:DIVISLAB, BOM:532488) consolidated attributable profit increased to 7.51 billion Indian rupees in the fiscal fourth quarter ended March 31, from 6.62 billion rupees a year ago.Earnings per share came in at 28.31 rupees from 24.93 rupees a year earlier, the pharmaceutical company said in a filing to the Indian bourses on Saturday. The EPS was higher than the 26.67 rupees estimated by analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 rose to 28.3 billion rupees from 25.9 billion rupees a year ago.The company's board recommended a final dividend of 30 rupees per equity share of face value 2 rupees each for the financial year 2025-26.